)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Samsung Biologics
Samsung Biologics (207940) investor relations material
Samsung Biologics Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary22 Apr, 2026
Executive summary
Achieved 26% year-over-year revenue growth in Q1 2026, marking 27 consecutive quarters of YoY growth.
Operating profit rose 35% YoY, with operating margin improving to 46.2%.
Full utilization of Plants 1 to 4 and ramp-up of Plant 5 supported strong performance.
Completed acquisition of a US manufacturing facility, expanding global footprint.
Secured new CMO and CDO projects, surpassing 440 cumulative CMO product approvals.
Financial highlights
Q1 2026 revenue: KRW 1,257B, up from KRW 1,000B in Q1 2025 (+26%).
Operating profit: KRW 581B, up from KRW 430B (+35%).
Net profit: KRW 331B, up from KRW 202B (+63.9%).
EBITDA: KRW 675B, EBITDA margin 53.7% (up 2.2 percentage points YoY).
Outlook and guidance
On track to meet annual guidance, supported by full operation of existing plants and Plant 5 ramp-up.
Forecasted annual revenue growth of 15-20%.
Rockville facility scalability and GSK volume
Drivers for the 15-20% annual revenue guidance
CEPI network reserve capacity and global role
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Samsung Biologics
- 30% revenue growth in 2025, major contracts, and global expansion drive strong outlook.207940
Q4 202521 Jan 2026 - Q3 2025 revenue up 40% YoY, operating profit up 115%, with strong CMO and biosimilar growth.207940Q3 202528 Oct 2025
- Q2 revenue up 11% YoY, guidance raised, record CDMO orders, and spin-off underway.207940Q2 202526 Oct 2025
- Q3 revenue surpassed KRW 3T, driven by strong CDMO growth and biosimilar milestones.207940Q3 202413 Jun 2025
- Q2 revenue up 34% YoY, with record contract wins and biosimilar approvals fueling growth.207940Q2 202413 Jun 2025
- Spin-off creates SEH to manage investments, enabling SBL and SBE to pursue focused growth.207940Investor Presentation6 Jun 2025
- Q1 2025 saw record growth, major contract wins, and strong biosimilar momentum.207940Q1 20256 Jun 2025
- Record revenue growth, major contract wins, and capacity expansion drive strong 2025 outlook.207940Q4 20245 Jun 2025
Next Samsung Biologics earnings date
Q2 202622 Jul, 2026
Samsung Biologics
Next Samsung Biologics earnings date
Q2 202622 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage